47000

Biopsy of liver, needle; percutaneous

Percutaneous liver biopsy (CPT code 47000) is a minimally invasive diagnostic procedure performed to obtain a sample of liver tissue for histopathological examination. This procedure is critical in the evaluation, diagnosis, and management of various hepatic disorders, including but not limited to chronic hepatitis (e.g., Hepatitis B and C), cirrhosis, unexplained hepatomegaly, abnormal liver function tests, hepatic steatosis, autoimmune liver diseases, and the characterization of focal liver lesions identified on prior imaging studies. The procedure begins with a thorough pre-operative assessment, including a review of coagulation profiles to ensure safe parameters for tissue extraction, as well as a review of relevant imaging studies. The patient is typically positioned supine or in a slight left lateral decubitus position to provide optimal access to the right hemithorax and upper abdomen. Following the identification of the optimal biopsy site, usually in the mid-axillary line between the seventh and ninth intercostal spaces (often under ultrasound or computed tomography guidance, which would be reported and billed separately), the overlying skin is widely prepped with an antiseptic solution and draped in a sterile fashion. Local anesthesia is administered to the skin, subcutaneous tissues, intercostal musculature, and the highly innervated liver capsule to ensure patient comfort throughout the procedure. A small stab incision is made, and a specialized biopsy needle (such as a Menghini, Jamshidi, or Tru-Cut core needle) is carefully advanced through the intercostal space and guided into the hepatic parenchyma. The patient is instructed to exhale fully and hold their breath in expiration to minimize diaphragmatic excursion, thereby reducing the risk of lacerating the liver or adjacent organs such as the lung or gallbladder. The needle is rapidly deployed and withdrawn to capture an intact cylindrical core of liver tissue. Depending on the clinical indication and the gross appearance of the initial sample, multiple needle passes may be required to obtain adequate tissue volume for comprehensive pathology. Once the sample is successfully secured, manual pressure is immediately applied to the biopsy site to achieve hemostasis, and a sterile adhesive dressing is applied. The patient is then transferred to a recovery area for strict bed rest and hemodynamic monitoring for several hours, with serial vital signs and abdominal assessments to detect any early signs of complications such as intraperitoneal hemorrhage, pneumothorax, or biliary leak. The extracted tissue is preserved in formalin or another appropriate transport medium and dispatched to the pathology laboratory for detailed microscopic and molecular analysis.

Clinical Indications

  • Unexplained elevation of liver enzymes (AST, ALT, Alkaline Phosphatase) persistent over several months.
  • Staging and grading of chronic viral liver diseases, such as Hepatitis B and Hepatitis C, to guide antiviral therapy.
  • Evaluation of hepatic steatosis, non-alcoholic fatty liver disease (NAFLD), or non-alcoholic steatohepatitis (NASH).
  • Definitive diagnosis of autoimmune hepatitis, primary biliary cholangitis, or primary sclerosing cholangitis.
  • Investigation of unexplained hepatomegaly or clinical suspicion of early cirrhosis.
  • Assessment of a liver allograft for suspected rejection, recurrent disease, or drug toxicity post-transplantation.
  • Diagnosis and quantification of inherited metabolic or storage disorders, such as hemochromatosis or Wilson's disease.

Procedure Steps

  1. Perform pre-procedure verification of patient identity, confirm informed consent, and review recent coagulation studies (PT/INR, platelets) to ensure procedural safety.
  2. Position the patient supine or in a left lateral decubitus position, exposing the right upper quadrant and lower right rib cage.
  3. Identify the optimal percutaneous biopsy site, typically in the mid-axillary line between the 7th and 9th intercostal spaces, often utilizing concurrent imaging guidance.
  4. Prepare the overlying skin with an antiseptic solution and apply sterile drapes to establish and maintain a sterile surgical field.
  5. Administer local anesthetic (e.g., 1% or 2% lidocaine) to the superficial skin, subcutaneous tissues, deeper intercostal muscles, and the liver capsule.
  6. Make a small stab incision in the anesthetized skin at the targeted needle insertion site using a scalpel.
  7. Instruct the patient to exhale completely and hold their breath to elevate the diaphragm and minimize respiratory organ movement.
  8. Insert the core biopsy needle (e.g., Tru-Cut or Menghini) through the stab incision, traversing the intercostal space directly into the liver parenchyma.
  9. Deploy the biopsy spring-mechanism or manual suction to sever and capture a core of liver tissue, then rapidly withdraw the needle.
  10. Eject the obtained tissue core directly into a sterile specimen container filled with an appropriate fixative solution (e.g., 10% neutral buffered formalin).
  11. Apply firm manual pressure to the needle insertion site for several minutes to promote hemostasis, followed by the application of a sterile pressure dressing.
  12. Transfer the patient to a recovery unit for mandatory bed rest and continuous vital sign monitoring to rule out post-procedural hemorrhage or pneumothorax.

Coding Guidelines

  • CPT 47000 is used exclusively for a percutaneous needle biopsy of the liver performed as an independent diagnostic procedure.
  • If radiological imaging guidance is utilized to localize the lesion or target the biopsy site (e.g., ultrasound, CT, or fluoroscopy), it must be reported separately using the appropriate imaging guidance code (e.g., 76942 for ultrasound guidance, 77012 for CT guidance).
  • Do not report 47000 in conjunction with 47001. If the needle liver biopsy is performed at the time of another major open or laparoscopic procedure for an indicated purpose, utilize the add-on code 47001 instead of 47000.
  • If a fine needle aspiration (FNA) is performed instead of a core needle biopsy, report the appropriate FNA code (e.g., 10021 for FNA without imaging guidance, or 10005 for FNA with ultrasound guidance) rather than 47000.
  • Surgical pathology services for the macroscopic and microscopic examination of the liver specimen are not included in 47000 and should be reported separately by the pathologist (typically using CPT 88307).
  • Code 47000 encompasses all required surgical steps to obtain the biopsy, including local anesthesia administration; therefore, do not bill separately for local anesthetic infiltration.

Associated ICD-10 Codes